Crossmark

Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06435-1

Published Online: 2022-06-16

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassett, Michael J. https://orcid.org/0000-0003-0754-3510
Wong, Sandra

Osarogiagbon, Raymond U.

Bian, Jessica

Dizon, Don S.

Jenkins, Hannah Hazard

Uno, Hajime

Cronin, Christine

Schrag, Deborah

,
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (1UM1CA233080-01)
License Information

Text and Data Mining valid from 2022-06-16

Version of Record valid from 2022-06-16
More Information

Article History

Received: 25 March 2022

Accepted: 27 May 2022

First Online: 16 June 2022

Declarations

:

: This protocol was approved for research as a minimal risk research study on November 25, 2018 (protocol #20182593), by the Western IRB.

: Not applicable — no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below